Mahamaya Lifesciences IPO Allotment Status: Check Steps To Verify Status
The bidding window for the Mahamaya Lifesciences SME IPO was open from November 11, 2025, to November 13, 2025. The basis of allotment will be finalised today, November 14, 2025. Here’s how you can check the IPO allotment status on the BSE and registrar’s website.
Procedure to Check Mahamaya Lifesciences IPO Allotment Status Online On BSE
- Click here to visit the application status page.
- In Issue Type, “Equity”.
- In Issue Name, select “Mahamaya Lifesciences LIMITED”.
- Enter your “Application No.” or “PAN No.”
- Click on “I am not a robot”.
- Click “Submit”.
Procedure to Check Mahamaya Lifesciences IPO Allotment Status on Kfin Technologies (Registrar to the issue)
- Visit the Kfin Technologies IPO allotment status page here.
- Click on any of the links.
- In Select IPO, select “Mahamaya Lifesciences Limited”.
- Enter any of the following details.
- PAN
- App. No.
- Demat Account
- Enter the captcha and click “Submit”.
IPO Details
Mahamaya Lifesciences IPO is a book-build issue of ₹70.44 crores, consisting of a fresh issue of ₹64.28 crores and an offer for sale of ₹6.16 crores. The price band is set between ₹108 and ₹114 per share. The tentative listing on BSE SME is November 18, 2025.
Oneview Corporate Advisors Pvt. Ltd. is the book-running lead manager, and Kfin Technologies is the registrar for the issue.
Use of Proceeds
The net proceeds from the fresh issue will be used to:
- Purchase equipment for existing Formulation plant and machinery
- Fund capital expenditure towards setting up of a new technical manufacturing plant and construction of warehouse building
- Fund working capital requirements
- General corporate purposes
Mahamaya Lifesciences IPO – Overall Subscription Status
(November 13, 2025, end of the day)
|
Category |
Subscription (times) |
|
Qualified Institutional Investors (QIBs) |
1.19 |
|
Non-Institutional Investors |
2.95 |
|
Individual Investors (IND category bidding for 2 Lots) |
1.02 |
|
Total |
1.59 |
Mahamaya Lifesciences Business Overview
Mahamaya Lifesciences is engaged in the manufacturing of high-quality pesticide formulations and the supply of bulk formulations to Indian agrochemical manufacturers and multinational corporations (MNCs).
For the FY ended March 31, 2024, the company recorded revenue from operations of ₹16,157.08 lakhs. In comparison, for the previous FY ended March 31, 2023, it was ₹13,707.58 lakhs, reflecting a year-on-year growth of 17.87%.
Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.
To read the RA disclaimer, please click here.